 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Kezar Life Sciences, Inc. Nasdaq:KZR, a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will present a corporate overview at the BIO CEO Investor Digital Conference, being held from February 16 18, 2021. Kezars Chief Scientific Officer, Chris Kirk, Ph.D., will participate in a panel discussion, Pr 